RAPT THERAPEUTICS, INC.
561 Eccles Avenue
South San Francisco, California 94080
February 4, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Paul Fischer
| Re: | RAPT Therapeutics, Inc. |
Registration Statement on FormS-1 (File No. 333-236256) |
Request for Acceleration of Effective Date |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, RAPT Therapeutics, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on FormS-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:15 p.m. Eastern time, on February 6, 2020, or as soon thereafter as possible, or at such other time as the Registrant may request by telephone to the Staff. The Registrant hereby authorizes each of Michael Tenta, Sale Kwon and Ryan James of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Michael Tenta of Cooley LLP at (650)843-5636 or, in his absence, Ryan James of Cooley LLP at (650)843-5846.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
[SIGNATUREPAGEFOLLOWS]
| Very truly yours, | ||
| RAPT THERAPEUTICS, INC. | ||
| By: | /s/ Rodney Young | |
| Name: Rodney Young | ||
| Title: Chief Financial Officer and Secretary | ||
[SIGNATURE PAGETO ACCELERATION REQUEST LETTER]
